BÜHLMANN Laboratories AG announces the nomination of Dr. Thomas Hafen as CEO, starting July 1st 2011. Roland P. Bühlmann continues to play an active role. files/documents/news/2011-06-27-buehlmann-labs-sets-structures-for-its-futre.doc.
Contact
BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
| Distributors Order About us Job opportunities |
Search in Blog
Archive
May 2013 [1]
September 2012 [1]
August 2012 [2]
July 2012 [1]
May 2012 [3]
March 2012 [1]
February 2012 [1]
December 2011 [1]
October 2011 [1]
September 2011 [2]
August 2011 [1]
July 2011 [1]
June 2011 [1]
May 2011 [1]
April 2011 [1]
February 2011 [1]
January 2011 [1]
October 2010 [1]
April 2010 [1]
February 2010 [1]
January 2010 [1]
December 2009 [3]
November 2009 [3]
October 2009 [1]
September 2009 [2]
August 2009 [2]
June 2009 [1]
April 2009 [1]
February 2009 [4]
September 2012 [1]
August 2012 [2]
July 2012 [1]
May 2012 [3]
March 2012 [1]
February 2012 [1]
December 2011 [1]
October 2011 [1]
September 2011 [2]
August 2011 [1]
July 2011 [1]
June 2011 [1]
May 2011 [1]
April 2011 [1]
February 2011 [1]
January 2011 [1]
October 2010 [1]
April 2010 [1]
February 2010 [1]
January 2010 [1]
December 2009 [3]
November 2009 [3]
October 2009 [1]
September 2009 [2]
August 2009 [2]
June 2009 [1]
April 2009 [1]
February 2009 [4]
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |